PBK/TOPK is upregulated in a wide range of mitotically active cancers; thus, a series of clinical studies have been conducted to investigate whether the levels of PBK/TOPK mRNA or protein have diagnostic or prognostic value [45]. Here, PBK is linked to cancer.